-
The Landscape of Antibiotic Development and Regulation in the United States and Europe, Alongside Evolving Industry Incentive Strategies
Sep 9, 2025, 16:22 PM -
Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
Burden of Disease and Healthcare Resource Use in Patients With Hereditary Transthyretin Amyloidosis in Spain: Findings From the OverTTuRe Global Study
Sep 9, 2025, 16:22 PM -
Integrated Sustainability Assessment of the Population-Based Colorectal Cancer Screening Program in Flanders
Sep 9, 2025, 16:22 PM -
Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective
Sep 9, 2025, 16:22 PM -
Overfitting Mitigation in Neural Networks: Could Ergodic Regularization Be the Future of AI?
Sep 9, 2025, 16:22 PM -
Economic and Clinical Impact of Older Adult Vaccination With the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico
Sep 9, 2025, 16:22 PM -
One Trial, Two Clocks: Coordinating EMA Assessment and Complementary EU HTA Evidence
Sep 9, 2025, 16:22 PM -
Treatment Patterns for Unresectable Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative and Triple-Negative Breast Cancers in France
Sep 9, 2025, 16:22 PM -
Comparative Efficacy of First-Line (1L) Therapies for Patients With Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (mCRPC): An Updated Systematic Literature Review (SLR) and Bayesian Network Meta-Analyses (NMAs)
Sep 9, 2025, 16:22 PM -
Experience of Single Dose IV Iron (Ferric Derisomaltose) Use in a Rural District General Medicine Ambulatory Unit and Overview of Its Economic and Sustainability Impact
Sep 9, 2025, 16:22 PM -
Millennial Medical Record (MMR) Data Profile: A Japanese Electronic Medical Records (EMRs) Database Utilizing Unstructured Data for Lung Cancer Research
Sep 9, 2025, 16:22 PM -
What Affects Quality of Life Most in Oral Cancer Therapy? A Pilot Study of Adherence and Side Effects
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Survival of Patients With HR+/HER2-negative Metastatic Breast Cancer After Treatment With CDK4/6-Inhibitors in Finland
Sep 9, 2025, 16:22 PM -
Analysis of ATC Equivalent Group and Therapeutic Reference Code Distributions Based on Drug Price and Reimbursement Lists in Türkiye Between 2020 and 2025
Sep 9, 2025, 16:22 PM -
Do Short-Term Outcome-Based Payments for Treatments Provide the Same Incremental Net Benefit As List Price Discounts?
Sep 9, 2025, 16:22 PM -
The Impact of Clinical Evidence on the Inclusion of Non-Small Cell Lung Cancer Drugs in Brazil's Supplementary Healthcare System
Sep 9, 2025, 16:22 PM -
Length of Stay (LOS) and Associated Healthcare Resource Use (HCRU) for a First Infusion of Axi-cel or Lisocel in Second Line for Large B-cell Lymphoma in France: Differences Observed From Comprehensive Hospital Databases
Sep 9, 2025, 16:22 PM -
The 90-Day Ambition: Historical Analysis of 200 NICE Appraisals to Assess Proportion-Achieving Final Guidance Within 90 Days of MHRA Approval
Sep 9, 2025, 16:22 PM -
Increased Trends of Self-Optimized Submissions to NICE
Sep 9, 2025, 16:22 PM
